TARRA MOORE: Open Payments
NPI 1477247146 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 28 payments from 14 companies in 2025. Trend: 2023 $391 · 2024 $857 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| GENZYME CORPORATION | 1 | $49 |
| PFIZER INC. | 2 | $40 |
| Amgen Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
Products named: REXULTI, Rybelsus, TRELEGY ELLIPTA, DUPIXENT, NURTEC ODT, EVENITY, BREZTRI, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
